Elizabeth Garrett-Mayer
伊丽莎白·加勒特-迈耶
PhD
Chief Research Officer, ASCO; Professor of Biostatistics美国临床肿瘤学会首席研究官；生物统计学教授
👥Biography 个人简介
Elizabeth Garrett-Mayer, PhD is a leading oncology biostatistician and Chief Research Officer at ASCO. A pioneer in adaptive clinical trial design and biomarker-driven oncology trials, she has shaped modern standards for cancer trial methodology and statistical innovation in precision oncology.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Adaptive Trial Design
Developed statistical frameworks for adaptive oncology trials, enabling real-time design modifications based on accumulating efficacy and safety data while preserving trial integrity and Type I error control.
Biomarker-Driven Clinical Trials
Advanced methodologies for incorporating predictive biomarkers into trial design, optimizing patient selection strategies and improving the efficiency of precision oncology studies.
Representative Works 代表性著作
Statistical Considerations for Biomarker-Driven Oncology Trials
Journal of Clinical Oncology (2022)
Comprehensive framework for integrating predictive biomarkers into adaptive oncology trial designs with rigorous statistical guarantees.
Adaptive Designs in Oncology: Current Status and Future Directions
Clinical Cancer Research (2021)
Overview of adaptive design applications in oncology, highlighting efficiency gains and regulatory considerations for modern cancer trials.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 伊丽莎白·加勒特-迈耶 的研究动态
Follow Elizabeth Garrett-Mayer's research updates
留下邮箱，当我们发布与 Elizabeth Garrett-Mayer（American Society of Clinical Oncology (ASCO) / Medical University of South Carolina）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment